Huajie Bu

681 total citations
11 papers, 510 citations indexed

About

Huajie Bu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Huajie Bu has authored 11 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Huajie Bu's work include Prostate Cancer Treatment and Research (6 papers), Ubiquitin and proteasome pathways (3 papers) and RNA Interference and Gene Delivery (2 papers). Huajie Bu is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Ubiquitin and proteasome pathways (3 papers) and RNA Interference and Gene Delivery (2 papers). Huajie Bu collaborates with scholars based in Austria, Germany and United States. Huajie Bu's co-authors include Helmut Klocker, Georg Schäfer, Lu Kong, Yuxiang Zhang, Michal R. Schweiger, Andrew C.B. Cato, Inger Rosdahl, Hong Zhang, Xiao‐Feng Sun and Lorenza Pasqualini and has published in prestigious journals such as Cancer Research, Molecular Cancer and Molecular Endocrinology.

In The Last Decade

Huajie Bu

11 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huajie Bu Austria 10 355 188 115 92 76 11 510
Urszula Oleksiewicz Poland 12 418 1.2× 152 0.8× 87 0.8× 118 1.3× 75 1.0× 22 572
Sara Koenig McLaughlin United States 4 337 0.9× 133 0.7× 87 0.8× 62 0.7× 141 1.9× 4 491
Laura Romero‐Pérez Spain 13 443 1.2× 292 1.6× 117 1.0× 117 1.3× 163 2.1× 14 710
Mark W. Zimmerman United States 12 530 1.5× 170 0.9× 47 0.4× 86 0.9× 121 1.6× 24 706
Ka Mun Nip Canada 7 353 1.0× 148 0.8× 320 2.8× 75 0.8× 152 2.0× 11 577
Jingxin Feng China 8 459 1.3× 184 1.0× 96 0.8× 43 0.5× 198 2.6× 13 604
Xia-Ying Kuang China 7 289 0.8× 234 1.2× 69 0.6× 68 0.7× 113 1.5× 9 442
Marli E. Ebus Netherlands 12 452 1.3× 162 0.9× 82 0.7× 71 0.8× 243 3.2× 14 681
Perry S. Mongroo United States 6 477 1.3× 308 1.6× 46 0.4× 68 0.7× 106 1.4× 6 642

Countries citing papers authored by Huajie Bu

Since Specialization
Citations

This map shows the geographic impact of Huajie Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huajie Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huajie Bu more than expected).

Fields of papers citing papers by Huajie Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huajie Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huajie Bu. The network helps show where Huajie Bu may publish in the future.

Co-authorship network of co-authors of Huajie Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Huajie Bu. A scholar is included among the top collaborators of Huajie Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huajie Bu. Huajie Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bu, Huajie, et al.. (2015). mir-24 activity propagates stress-induced senescence by down regulating DNA topoisomerase 1. Experimental Gerontology. 75. 48–52. 14 indexed citations
2.
Santer, Frédéric R., Holger H.H. Erb, Su Jung Oh, et al.. (2015). Abstract 3: Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy. Cancer Research. 75(15_Supplement). 3–3. 5 indexed citations
3.
Pasqualini, Lorenza, Huajie Bu, Martin Puhr, et al.. (2015). miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer. Molecular Endocrinology. 29(7). 1037–1054. 65 indexed citations
4.
Bu, Huajie, Narisu Narisu, Bettina Schlick, et al.. (2015). Putative Prostate Cancer Risk SNP in an Androgen Receptor‐Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites. Human Mutation. 37(1). 52–64. 26 indexed citations
5.
Santer, Frédéric R., Holger H.H. Erb, Su Jung Oh, et al.. (2015). Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy. Oncotarget. 6(8). 6105–6122. 29 indexed citations
6.
Köhler, Andrea, Sybille Krauß, J. Aigner, et al.. (2014). A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling. Molecular Cancer. 13(1). 146–146. 35 indexed citations
7.
Neeb, Antje, Walther Parson, Fabian Adams, et al.. (2014). Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer. Oncotarget. 5(18). 8681–8689. 36 indexed citations
8.
Bu, Huajie, Michal R. Schweiger, Thomas Manke, et al.. (2013). Anterior gradient 2 and 3 – two prototype androgen‐responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells. FEBS Journal. 280(5). 1249–1266. 39 indexed citations
10.
Bu, Huajie, Georg Schäfer, Wolfgang Horninger, et al.. (2010). The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. The Prostate. 71(6). 575–587. 77 indexed citations
11.
Bu, Huajie, Inger Rosdahl, Xiao‐Feng Sun, & Hong Zhang. (2007). Importance of polymorphisms in NF-κB1 and NF-κBIα genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. Journal of Cancer Research and Clinical Oncology. 133(11). 859–866. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026